Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 97 Results

Intervention Indication Therapeutic Area Year Actions
Ribociclib with endocrine therapy for HR+/HER2- early breast cancer – adjuvant treatment Endocrine therapy , Ribociclib (Kisqali; LEE-011; ribociclib succinate) Breast cancer Breast Cancer 2022 View  |  Download
REGN5458 for relapsed or refractory multiple myeloma REGN5458 Multiple myeloma (MM) Haematological Cancer and Lymphomas 2022 View  |  Download
Ravulizumab for treatment of neuromyelitis optica spectrum disorder Ravulizumab (ALXN1210; Ultomiris) Neuromyelitis optica spectrum disorders Nephrology , Ophthalmology 2022 View  |  Download
Ranibizumab port delivery system for treating
diabetic macular oedema
Ranibizumab (Lucentis Port Delivery System; Lucentis) Diabetic macular oedema Endocrine, nutritional and metabolic disorders , Ophthalmology 2022 View  |  Download
Pembrolizumab with stereotactic body radiotherapy for unresected stage I or II non-small cell lung cancer Pembrolizumab (Keytruda; MK-3475) , Stereotactic body radiotherapy Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2022 View  |  Download
Pembrolizumab with enzalutamide for treating
metastatic castration-resistant prostate cancer
Enzalutamide (Xtandi; MDV3100) , Pembrolizumab (Keytruda; MK-3475) Prostate cancer Male Reproductive Cancer 2022 View  |  Download
Pembrolizumab with chemoradiotherapy for treating high-risk locally advanced cervical cancer Chemoradiotherapy , Pembrolizumab (Keytruda; MK-3475) Cervical cancer Female Reproductive Cancer 2022 View  |  Download
Pembrolizumab and chemotherapy for resectable nonsmall-cell lung cancer Pembrolizumab (Keytruda; MK-3475) Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2022 View  |  Download
Oxybutynin hydrochloride for treating neurogenic detrusor overactivity Oxybutynin hydrochloride (Vesoxx) Neurogenic detrusor overactivity Neurology , Urology 2022 View  |  Download
Otilimab in combination with conventional synthetic DMARDs for treating rheumatoid arthritis Otilimab Rheumatoid arthritis Rheumatology 2022 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications